Compare · AIDX vs ULS
AIDX vs ULS
Side-by-side comparison of 20/20 Biolabs Inc. (AIDX) and UL Solutions Inc. (ULS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIDX and ULS operate in Precision Instruments (Health Care), so they compete in similar markets.
- ULS is the larger of the two at $14.94B, about 2214.7x AIDX ($6.7M).
- ULS has been more active in the news (11 items in the past 4 weeks vs 7 for AIDX).
- ULS has more recent analyst coverage (7 ratings vs 0 for AIDX).
- Company
- 20/20 Biolabs Inc.
- UL Solutions Inc.
- Price
- -
- -
- Market cap
- $6.7M
- $14.94B
- 1M return
- -
- -17.72%
- 1Y return
- -
- +17.20%
- Industry
- Precision Instruments
- Precision Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 7
- 11
- Recent ratings
- 0
- 7
Latest AIDX
- SEC Form DEFA14A filed by 20/20 Biolabs Inc.
- 20/20 Biolabs Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 424B3 filed by 20/20 Biolabs Inc.
- SEC Form 424B3 filed by 20/20 Biolabs Inc.
- 20/20 Biolabs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
- 20/20 Biolabs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- 20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
- 20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
- 20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock
Latest ULS
- UL Solutions Expands Capabilities in Italy to Create European Retail Center of Excellence Supporting Customers From Product Concept to Market
- UL Solutions Launches Retail Total Access™ Software to Help Retailers Manage Supply Chain Quality and Risk
- UL Solutions Announces Quarterly Dividend
- Amendment: SEC Form SCHEDULE 13G/A filed by UL Solutions Inc.
- Director Shannon James M gifted 600 shares, decreasing direct ownership by 8% to 6,542 units (SEC Form 4)
- UL Solutions to Attend Upcoming Investor Conferences
- President and CEO Scanlon Jennifer F. sold $1,151,030 worth of shares (12,500 units at $92.08) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 151,724 units (SEC Form 4)
- SEC Form 10-Q filed by UL Solutions Inc.
- UL Solutions Inc. Reports Strong Second Quarter 2026 Results
- UL Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits